Discovering new bioactive molecules from microbial sources

Microbial Biotechnology

Volumn 7, Issue 3, 2014, Pages 209-220

  Monciardini, Paolo ^a   Iorio, Marianna ^a   Maffioli, Sonia ^a   Sosio, Margherita ^a   Donadio, Stefano ^a  

^a NAICONS Srl   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GE 82832; MICROBIAL PRODUCTS NOT CLASSIFIED ELSEWHERE; NAI 112; NATURAL PRODUCT; ORTHOFORMIMYCIN; PUROMYCIN; TETRACYCLINE; UNCLASSIFIED DRUG; BIOLOGICAL PRODUCT;

ACINETOBACTER BAUMANNII; ACTINOBACTERIA; ARTICLE; ASPERGILLUS FUMIGATUS; BACTERIAL CELL WALL; BIOSYNTHESIS; CANDIDA ALBICANS; DRUG SCREENING; GROWTH INHIBITION; HIGH THROUGHPUT SCREENING; METAGENOME; MICROBIAL DIVERSITY; MICROBIAL GENOME; MINING; NONHUMAN; PREDICTION; PSEUDOMONAS AERUGINOSA; RESPIRATORY CHAIN; STENOTROPHOMONAS MALTOPHILIA; STIGMATELLA AURANTIACA; STREPTOCOCCUS PYOGENES; STREPTOMYCES AVERMITILIS; STREPTOMYCES COELICOLOR; CHEMISTRY; FUNGUS; ISOLATION AND PURIFICATION; PROCEDURES;

ACTINOBACTERIA; BIOLOGICAL PRODUCTS; DRUG EVALUATION, PRECLINICAL; FUNGI;

EID: 84897938547     PISSN: 17517907     EISSN: 17517915     Source Type: Journal    
DOI: 10.1111/1751-7915.12123     Document Type: Article

References (72)

1. Aigle, B., and Corre, C. (2012) Waking up Streptomyces secondary metabolism by constitutive expression of activators or genetic disruption of repressors. Methods Enzymol 517: 343-366.
2. Arnison, P.G., Bibb, M.J., Bierbaum, G., Bowers, A.A., Bugni, T.S., Bulaj, G., etal. (2013) Ribosomally synthesized and post-translationally modified peptide natural products: overview and recommendations for a universal nomenclature. Nat Prod Rep 30: 108-160.
3. Baltz, R.H. (2005) Antibiotic discovery from actinomycetes: will a renaissance follow the decline and fall? SIM News 55: 186-196.
4. Baltz, R.H. (2007) Antimicrobials from actinomycetes: back to the future. Microbe 2: 125-131.
5. Baltz, R.H. (2008) Renaissance in antibacterial discovery from actinomycetes. Curr Opin Pharmacol 8: 557-563.
6. Banik, J.J., and Brady, S.F. (2010) Recent application of metagenomic approaches toward the discovery of antimicrobials and other bioactive small molecules. Curr Opin Microbiol 13: 603-609.
7. Bérdy, J. (2005) Bioactive microbial metabolites. J Antibiot 58: 1-26.
8. Bérdy, J. (2012) Thoughts and facts about antibiotics: where we are now and where we are heading. J Antibiot 65: 385-395.
9. Bister, B., Bischoff, D., Ströbele, M., Riedlinger, J., Reicke, A., Wolter, F., etal. (2004) Abyssomicin C-A polycyclic antibiotic from a marine Verrucosispora strain as an inhibitor of the p-aminobenzoic acid/tetrahydrofolate biosynthesis pathway. Angew Chem Int Ed Engl 43: 2574-2576.
10. Blin, K., Medema, M.H., Kazempour, D., Fischbach, M.A., Breitling, R., Takano, E., and Weber, T. (2013) antiSMASH 2.0 - a versatile platform for genome mining of secondary metabolite producers. Nucleic Acids Res 41: W204-W212.
11. Brandi, L., Fabbretti, A., La Teana, A., Abbondi, M., Losi, D., Donadio, S., and Gualerzi, C.O. (2006a) Specific, efficient, and selective inhibition of prokaryotic translation initiation by a novel peptide antibiotic. Proc Natl Acad Sci USA 103: 39-44.
12. Brandi, L., Fabbretti, A., Di Stefano, M., Lazzarini, A., Abbondi, M., and Gualerzi, C.O. (2006b) Characterization of GE82832, a peptide inhibitor of translocation interacting with bacterial 30S ribosomal subunits. RNA 12: 1262-1270.
13. Brandi, L., Fabbretti, A., Milon, P., Carotti, M., Pon, C.L., and Gualerzi, C.O. (2007) Methods for identifying compounds that specifically target translation. Methods Enzymol 431: 229-267.
14. Brandi, L., Maffioli, S., Donadio, S., Quaglia, F., Sette, M., Milón, P., etal. (2012) Structural and functional characterization of the bacterial translocation inhibitor GE82832. FEBS Lett 586: 3373-3378.
15. Bull, A.T. (2003) Microbial Diversity and Bioprospecting. Washington, DC: Americal Society for Microbiology.
16. Busti, E., Cavaletti, L., Monciardini, P., Schumann, P., Rohde, M., Sosio, M., and Donadio, S. (2006a) Catenulispora acidiphila gen. nov., sp. nov., a novel mycelium-forming actinomycete and proposal of Catenulisporaceae fam. nov. Int J Syst Evol Microbiol 56: 1741-1756.
17. Busti, E., Monciardini, P., Cavaletti, L., Bamonte, R., Lazzarini, A., Sosio, M., and Donadio, S. (2006b) Antibiotic-producing ability by representatives of a newly discovered lineage of actinomycetes. Microbiology 152: 675-683.
18. Castiglione, F., Lazzarini, A., Carrano, L., Corti, E., Ciciliato, I., Gastaldo, L., etal. (2008) Determining the structure and mode of action of microbisporicin, a potent lantibiotic active against multiresistant pathogens. Chem Biol 15: 22-31.
19. Cavaletti, L., Monciardini, P., Schumann, P., Rohde, M., Bamonte, R., Busti, E., etal. (2006) Actinospica acidiphila gen. nov., sp. nov., and Actinospica robiniae gen. nov., sp. nov.; proposal for Actinospicaceae fam. nov. and Catenulisporinae subordo nov. in the order Actinomycetales. Int J Syst Evol Microbiol 56: 1747-1753.
20. Corre, C., and Challis, G.L. (2009) New natural product biosynthetic chemistry discovered by genome mining. Nat Prod Rep 26: 977-986.
21. Davies, J. (2013) Specialized microbial metabolites: functions and origins. J Antibiot 66: 361-364.
22. Davies, J., and Ryan, K.S. (2012) Introducing the parvome: bioactive compounds in the microbial world. ACS Chem Biol 7: 252-259.
23. Demain, A.L. (2014) Importance of microbial natural products and the need to revitalize their discovery. J Ind Microbiol Biotechnol 41: 185-201. 2013 Aug 30.
24. Donadio, S., Monciardini, P., Alduina, R., Mazza, P., Chiocchini, C., Cavaletti, L., etal. (2002) Microbial technologies for the discovery of novel bioactive metabolites. J Biotechnol 99: 187-198.
25. Donadio, S., Busti, E., Monciardini, P., Bamonte, R., Mazza, P., Sosio, M., and Cavaletti, L. (2005) Sources of polyketides and non-ribosomal peptides. Ernst Schering Res Found Workshop 51: 19-41.
26. Donadio, S., Monciardini, P., and Sosio, M. (2007) Polyketide synthases and nonribosomal peptide synthetases: the emerging view from bacterial genomics. Nat Prod Rep 24: 1073-1109.
27. Donadio, S., Monciardini, P., and Sosio, M. (2009) Approaches to discovering novel antibacterial and antifungal agents. Methods Enzymol 438: 3-28.
28. Esquenazi, E., Yang, Y.L., Watrous, J., Gerwick, W.H., and Dorrestein, P.C. (2009) Imaging mass spectrometry of natural products. Nat Prod Rep 26: 1521-1534.
29. Fenical, W., and Jensen, P.R. (2006) Developing a new resource for drug discovery: marine actinomycete bacteria. Nat Chem Biol 2: 666-673.
30. Ferrer, M., Beloqui, A., Timmis, K.N., and Golyshin, P.N. (2009) Metagenomics for mining new genetic resources of microbial communities. J Mol Microbiol Biotechnol 16: 109-123.
31. Fischbach, M.A., and Walsh, C.T. (2009) Antibiotics for emerging pathogens. Science 325: 1089-1093.
32. Fischer, H.P., Brunner, N.A., Wieland, B., Paquette, J., Macko, L., Ziegelbauer, K., and Freiberg, C. (2004) Identification of antibiotic stress-inducible promoters: a systematic approach to novel pathway-specific reporter assays for antibacterial drug discovery. Genome Res 14: 90-98.
33. Genilloud, O., Gonzalez, I., Salazar, O., Martin, J., Tormo, J.R., and Vicente, F. (2011) Current approaches to exploit actinomycetes as a source of novel natural products. J Ind Microbiol Biotechnol 38: 375-389.
34. Gomez-Escribano, J.P., and Bibb, M.J. (2014) Heterologous expression of natural product biosynthetic gene clusters in Streptomyces coelicolor: from genome mining to manipulation of biosynthetic pathways. J Ind Microbiol Biotechnol 41: 425-431.
35. Gross, H., Stockwell, V.O., Henkels, M.D., Nowak-Thompson, B., Loper, J.E., and Gerwick, W.H. (2007) The genomisotopic approach: a systematic method to isolate products of orphan biosynthetic gene clusters. Chem Biol 14: 53-63.
36. Gualerzi, C.O., Brandi, L., Fabbretti, A., and Pon, C.L. (2013) Antibiotics: Targets, Mechanisms and Resistance. Weinheim, Germany: Wiley-VCH.
37. Gulder, T.A., and Moore, B.S. (2010) Salinosporamide natural products: potent 20S proteasome inhibitors as promising cancer chemotherapeutics. Angew Chem Int Ed Engl 49: 9346-9367.
38. Iorio, M., Sasso, O., Maffioli, S.I., Bertorelli, R., Monciardini, P., Sosio, M., etal. (2014) A glycosylated, labionin-containing lanthipeptide with marked antinociceptive activity. ACS Chem Biol 9: 398-404.
39. Jabés, D., and Donadio, S. (2010) Strategies for the isolation and characterization of antibacterial lantibiotics. Methods Mol Biol 618: 31-45.
40. Jabés, D., Brunati, C., Candiani, G., Riva, S., Romanó, G., and Donadio, S. (2011) Efficacy of the new lantibiotic NAI-107 in experimental infections induced by multidrug-resistant Gram-positive pathogens. Antimicrob Agents Chemother 55: 1671-1676.
41. Kim, T.K., Hewavitharana, A.K., Shaw, P.N., and Fuerst, J.A. (2006) Discovery of a new source of rifamycin antibiotics in marine sponge actinobacteria by phylogenetic prediction. Appl Environ Microbiol 72: 2118-2125.
42. Lancini, G. (2006) Forty years of antibiotic discovery at Lepetit: a personal journey. SIM News 56: 192-212.
43. Laureti, L., Song, L., Huangm, S., Correm, C., Leblond, P., Challis, G.L., and Aigle, B. (2011) Identification of a bioactive 51-membered macrolide complex by activation of a silent polyketide synthase in Streptomyces ambofaciens. Proc Natl Acad Sci USA 108: 6258-6263.
44. Lautru, S., Deeth, R.J., Bailey, L.M., and Challis, G.L. (2005) Discovery of a new peptide natural product by Streptomyces coelicolor genome mining. Nat Chem Biol 1: 265-269.
45. Lazzarini, A., Cavaletti, L., Toppo, G., and Marinelli, F. (2000) Rare genera of actinomycetes as potential producers of new antibiotics. Antonie Van Leeuwenhoek 79: 399-405.
46. Letzel, A.C., Pidot, S.J., and Hertweck, C. (2013) A genomic approach to the cryptic secondary metabolome of the anaerobic world. Nat Prod Rep 30: 392-428.
47. McAlpine, J.B., Bachmann, B.O., Piraee, M., Tremblay, S., Alarco, A.M., Zazopoulos, E., and Farnet, C.M. (2005) Microbial genomics as a guide to drug discovery and structural elucidation: ECO-02301, a novel antifungal agent, as an example. J Nat Prod 68: 493-496.
48. Maffioli, S., Potenza, D., Vasila, F., De Matteo, M., Sosio, M., Marsiglia, B., etal. (2009) Structure revision of the lantibiotic 97518. J Nat Prod 72: 605-607.
49. Maffioli, S.I., Fabbretti, A., Brandi, L., Savelsbergh, A., Monciardini, P., Abbondi, M., etal. (2013) Orthoformimycin, a selective inhibitor of bacterial translation elongation from Streptomyces containing an unusual orthoformate. ACS Chem Biol 8: 1939-1946.
50. Mazzetti, C., Ornaghi, M., Gaspari, E., Parapini, S., Maffioli, S., Sosio, M., and Donadio, S. (2012) Halogenated spirotetronates from Actinoallomurus. J Nat Prod 75: 1044-1050.
51. Medema, M.H., Breitling, R., Bovenberg, R., and Takano, E. (2011) Exploiting plug-and-play synthetic biology for drug discovery and production in microorganisms. Nat Rev Microbiol 9: 131-137.
52. Meindl, K., Schmiederer, T., Schneider, K., Reicke, A., Butz, D., Keller, S., etal. (2010) Labyrinthopeptins: a new class of carbacyclic lantibiotics. Angew Chem Int Ed 49: 1151-1154.
53. Monciardini, P., Cavaletti, L., Ranghetti, A., Schumann, P., Rohde, M., Bamonte, R., etal. (2009) Two novel members of the family Micromonosporaceae, Rugosimonospora acidiphila gen. nov, sp. nov. and Rugosimonospora africana sp. nov. Int J Syst Evol Microbiol 59: 2752-2758.
54. Newman, D.J., and Cragg, G.M. (2012) Natural products as sources of new drugs over the 30 years from 1981 to 2010. J Nat Prod 75: 311-335.
55. Oh, D.C., Williams, P.G., Kauffman, C.A., Jensen, P.R., and Fenical, W. (2006) Cyanosporasides A and B, chloro- and cyano-cyclopenta[a]indene glycosides from the marine actinomycete 'Salinispora pacifica'. Org Lett 8: 1021-1024.
56. Piel, J. (2009) Metabolites from symbiotic bacteria. Nat Prod Rep 26: 338-362.
57. Piel, J. (2011) Approaches to capturing and designing biologically active small molecules produced by uncultured microbes. Annu Rev Microbiol 65: 431-453.
58. Pozzi, R., Simone, M., Mazzetti, C., Maffioli, S., Monciardini, P., Cavaletti, L., etal. (2011) The genus Actinoallomurus and some of its metabolites. J Antibiot 64: 133-139.
59. Roemer, T., Jiang, B., Davison, J., Ketela, T., Veillette, K., Breton, A., etal. (2003) Large-scale essential gene identification in Candida albicans and applications to antifungal drug discovery. Mol Microbiol 50: 167-181.
60. Simone, M., Monciardini, P., Gaspari, E., Donadio, S., and Maffioli, S.I. (2013) Isolation and characterization of NAI-802, a new lantibiotic produced by two different Actinoplanes strains. J Antibiot 66: 73-78.
61. Singh, S.B., Phillips, J.W., and Wang, J. (2007) Highly sensitive target-based whole-cell antibacterial discovery strategy by antisense RNA silencing. Curr Opin Drug Discov Devel 10: 160-166.
62. Singh, S.B., Zink, D.L., Dorso, K., Motyl, M., Salazar, O., Basilio, A., etal. (2009) Isolation, structure, and antibacterial activities of lucensimycins D-G, discovered from Streptomyces lucensis MA7349 using an antisense strategy. J Nat Prod 72: 345-352.
63. Tamura, T., Ishida, Y., Nozawa, Y., Otoguro, M., and Suzuki, K. (2009) Transfer of Actinomadura spadix Nonomura and Ohara 1971 to Actinoallomurus spadix gen. nov., comb. nov., and description of Actinoallomurus amamiensis sp. nov., Actinoallomurus caesius sp. nov., Actinoallomurus coprocola sp. nov., Actinoallomurus fulvus sp. nov., Actinoallomurus iriomotensis sp. nov., Actinoallomurus luridus sp. nov., Actinoallomurus purpureus sp. nov. and Actinoallomurus yoronensis sp. nov. Int J Syst Evol Microbiol 59: 1867-1874.
64. Thaker, M.N., Wang, W., Spanogiannopoulos, P., Waglechner, N., King, A.M., Medina, R., and Wright, G.D. (2013) Identifying producers of antibacterial compounds by screening for antibiotic resistance. Nat Biotechnol 31: 922-927.
65. Tu, Y., and Yan, B. (2012) High-throughput fractionation of natural products for drug discovery. Methods Mol Biol 918: 117-126.
66. Urban, A., Eckermann, S., Fast, B., Metzger, S., Gehling, M., Ziegelbauer, K., etal. (2007) Novel whole-cell antibiotic biosensors for compound discovery. Appl Environ Microbiol 73: 6436-6443.
67. Wang, H., and van der Donk, W.A. (2012) Biosynthesis of the class III lantipeptide catenulipeptin. ACS Chem Biol 7: 1529-1535.
68. Wang, J., Soisson, S.M., Young, K., Shoop, W., Kodali, S., Galgoci, A., etal. (2006) Platensimycin is a selective FabF inhibitor with potent antibiotic properties. Nature 441: 358-361.
69. Wenzel, S.C., and Müller, R. (2009) The impact of genomics on the exploitation of the myxobacterial secondary metabolome. Nat Prod Rep 26: 1385-1407.
70. Zazopoulos, E., Huang, K., Staffa, A., Liu, W., Bachmann, B.O., Nonaka, K., etal. (2003) A genomics-guided approach for discovering and expressing cryptic metabolic pathways. Nat Biotechnol 21: 187-190.
71. Zengler, K., Toledo, G., Rappe, M., Elkins, J., Mathur, E.J., Short, J.M., and Keller, M. (2002) Cultivating the uncultured. Proc Natl Acad Sci USA 99: 15681-15686.
72. Zhang, C., Occi, J., Masurekar, P., Barrett, J.F., Zink, D.L., Smith, S., etal. (2008) Isolation, structure, and antibacterial activity of philipimycin, a thiazolyl peptide discovered from Actinoplanes philippinensis MA7347. J Am Chem Soc 130: 12102-12110.